How to Increase the Immunogenicity of SARS-COV-2 Inactivated Vaccines?
Abstract
No Abstract
1. Lin A, Liu J, Ma X, et al. Heterologous vaccination strategy for containing COVID-19 pandemic. Media 2021:2021.05.17.21257134.
2. Zhang J, He Q, An C, et al. Boosting with heterologous vaccines effectively improves protective immune responses of the inactivated SARS-CoV-2 vaccine. Emerg Microbes Infect 2021;10(1):1598-608.
3. He Q, Mao Q, An C, et al. Heterologous prime-boost: breaking the protective immune response bottleneck of COVID-19 vaccine candidates. Emerg Microbes Infect 2021;10(1):629-37.
4. European Centre for Disease Prevention and Control. Partial COVID-19 vaccination, vaccination following SARS-CoV-2 infection and heterologous vaccination schedule: summary of evidence. 22 July 2021. ECDC: Stockholm; 2021.
2. Zhang J, He Q, An C, et al. Boosting with heterologous vaccines effectively improves protective immune responses of the inactivated SARS-CoV-2 vaccine. Emerg Microbes Infect 2021;10(1):1598-608.
3. He Q, Mao Q, An C, et al. Heterologous prime-boost: breaking the protective immune response bottleneck of COVID-19 vaccine candidates. Emerg Microbes Infect 2021;10(1):629-37.
4. European Centre for Disease Prevention and Control. Partial COVID-19 vaccination, vaccination following SARS-CoV-2 infection and heterologous vaccination schedule: summary of evidence. 22 July 2021. ECDC: Stockholm; 2021.
| Files | ||
| Issue | Vol 9, No 4 (Autumn 2021) | |
| Section | Letter to the Editor | |
| DOI | https://doi.org/10.18502/jpc.v9i4.8227 | |
| Keywords | ||
| Vaccines | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
How to Cite
1.
Khadivi Y. How to Increase the Immunogenicity of SARS-COV-2 Inactivated Vaccines?. J Pharm Care. 2021;9(4):227.
